What You Need to Know Ahead of MetLife's Earnings Release
π MetLife is expected to announce fiscal 2026 third-quarter earnings on Wednesday, Nov. 4 after the market closes.
π° Analysts project a diluted profit of $2.71 per share for Q3 2026, up 15.8% from $2.34 in the year-ago quarter.
π The company has beaten consensus estimates in each of the last four quarters.
π Full-year analysts expect MET to report EPS of $9.94 for fiscal 2026, up 11.8% from fiscal 2025.
π MetLife stock is up 26.4% over the past 52 weeks, outperforming the S&P 500's 13.1% gains.
π΅ Net premiums earned increased by 2.7% annually over the past five years for MetLife.
π EPS grew by 3.3% per year over the last five years for the insurer.
πΈ MetLife declared a Q4 2026 cash dividend of $0.5925 per share on Oct. 6.
π The dividend is scheduled to be paid on December 8, 2026, to shareholders of record as of Nov. 3, 2026.
π Analyst consensus rating for MET stock is Moderate Buy with 12 out of 19 analysts advising Strong Buy.
π― Average analyst price target is $108.76, indicating potential upside of 10.1% from current levels.
- MetLife stock has outperformed the S&P 500 Index by 13.3 percentage points over the past 52 weeks, rising 26.4% compared to the index's 13.1% gains.
- The company has beaten consensus estimates in each of the last four quarters, demonstrating consistent performance above market expectations.
- Over the past five years, MetLife achieved a compound annual growth rate of 2.7% in net premiums earned and 3.3% in earnings per share.
- Analysts project a 15.8% year-over-year increase in diluted profit to $2.71 per share for the upcoming fiscal 2026 third quarter.
- The board declared a fourth-quarter 2026 cash dividend of $0.5925 per common share, signaling commitment to returning capital to shareholders.
- Full-year analysts expect EPS of $9.94 for fiscal 2026, representing an 11.8% increase from the previous year's $8.89.
- The average analyst price target of $108.76 suggests a potential upside of 10.1% from current trading levels.